1
STATE OF OKLAHOMA
1
2
1st Session of the 60th Legislature (2025)
2
3
SENATE BILL 927 By: Hicks
3
4
4
5
5
6
AS INTRODUCED
6
7
An Act relating to the state Medicaid program;
7
amending 63 O.S. 2021, Section 5030.1, which relates
8
to the Medicaid Drug Utilization Review Board;
8
modifying appointment procedure for certain members;
9
updating statutory language; and providing an
9
effective date.
10
10
11
11
12
BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
12
13
SECTION 1. AMENDATORY 63 O.S. 2021, Section 5030.1, is
13
14
amended to read as follows:
14
15
Section 5030.1. A. There is hereby created within the Oklahoma
15
16
Health Care Authority the Medicaid Drug Utilization Review Board,
16
17
which shall be responsible for the development, implementation and
17
18
assessment of retrospective and prospective drug utilization
18
19
programs under the direction of the Authority.
19
20
B. The Medicaid Drug Utilization Review Board shall consist of
20
21
ten (10) members appointed by the administrator of the Authority as
21
22
follows:
22
23
23
24
24
Req. No. 1099 Page 1

1
1. Four physicians, licensed and actively engaged in the
1
2
practice of medicine or osteopathic medicine in this state, of
2
3
which:
3
4
a. three shall be physicians, each of whom is chosen from
4
5
a list of not less than six three names submitted by
5
6
the Oklahoma State Medical Association, and
6
7
b. one shall be a physician chosen from a list of not
7
8
less than two names submitted by the Oklahoma
8
9
Osteopathic Association;
9
10
2. Four licensed pharmacists actively engaged in the practice
10
11
of pharmacy, chosen from a list of not less than six names submitted
11
12
by the Oklahoma Pharmaceutical Pharmacists Association;
12
13
3. One person representing the lay community, who shall not be
13
14
a physician or a pharmacist, but shall be a health care professional
14
15
with recognized knowledge and expertise in at least one of the
15
16
following:
16
17
a. clinically appropriate prescribing of covered
17
18
outpatient drugs,
18
19
b. clinically appropriate dispensing and monitoring of
19
20
covered outpatient drugs,
20
21
c. drug use review, evaluation and intervention, and
21
22
d. medical quality assurance; and
22
23
4. One person representing the pharmaceutical industry who is a
23
24
resident of the State of Oklahoma this state, chosen from a list of
24
Req. No. 1099 Page 2

1
not less than two names submitted by the Pharmaceutical Research and
1
2
Manufacturers of America. The member representing the
2
3
pharmaceutical industry shall be prohibited from voting on action
3
4
items involving drugs or classes of drugs.
4
5
C. Members shall serve terms of three (3) years, except that
5
6
one physician, one pharmacist and the lay representative shall each
6
7
be initially appointed for two-year terms in order to stagger the
7
8
terms. In making the appointments, the administrator shall provide,
8
9
to the extent possible, for geographic balance in the representation
9
10
on the Medicaid Drug Utilization Review Board. Members may be
10
11
reappointed for a period not to exceed three three-year terms and
11
12
one partial term. Vacancies on the Medicaid Drug Utilization Review
12
13
Board shall be filled for the balance of the unexpired term from new
13
14
lists submitted by the entity originally submitting the list for the
14
15
position vacated.
15
16
D. The Medicaid Drug Utilization Review Board shall elect from
16
17
among its members a chair and a vice-chair vice chair who shall
17
18
serve one-year terms, provided they may succeed themselves.
18
19
E. The proceedings of all meetings of the Medicaid Drug
19
20
Utilization Review Board shall comply with the provisions of the
20
21
Oklahoma Open Meeting Act and shall be subject to the provisions of
21
22
the Administrative Procedures Act.
22
23
F. The Medicaid Drug Utilization Review Board may advise and
23
24
make recommendations to the Authority regarding existing, proposed
24
Req. No. 1099 Page 3

1
and emergency rules governing retrospective and prospective drug
1
2
utilization programs. The Oklahoma Health Care Authority Board
2
3
shall promulgate rules pursuant to the provisions of the
3
4
Administrative Procedures Act for implementation of the provisions
4
5
of this section.
5
6
SECTION 2. This act shall become effective November 1, 2025.
6
7
7
8
60-1-1099 DC 1/19/2025 5:46:08 AM
8
9
9
10
10
11
11
12
12
13
13
14
14
15
15
16
16
17
17
18
18
19
19
20
20
21
21
22
22
23
23
24
24
Req. No. 1099 Page 4

[DELETED:  P B H]
[DELETED:  P t o c c d m]
[DELETED:  P]
[DELETED:  P D 1]